Title
Secukinumab Provides Greater Skin Clearance and Improvement in Skin-Related Quality of Life Than Ustekinumab for Biologic-Naive Patients With Psoriasis: Results From the CLEAR 52-Week Study
Document Type
Abstract
Publication Date
June 2017
Department
Dermatology
Recommended Citation
Gottlieb, A., Lebwohl, M., Gilloteau, I., Zhou, Y., Guana, A., Sherif, B., & Puig, L. (2017). Secukinumab Provides Greater Skin Clearance and Improvement in Skin-Related Quality of Life Than Ustekinumab for Biologic-Naive Patients With Psoriasis: Results From the CLEAR 52-Week Study. Journal of the American Academy of Dermatology, 76 (6 Suppl. 1), AB231. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/46
COinS
